Astrocytoma medical therapy

Revision as of 16:56, 24 August 2015 by Ammu Susheela (talk | contribs)
Jump to navigation Jump to search

Astrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Astrocytoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma medical therapy

CDC on Astrocytoma medical therapy

Astrocytoma medical therapy in the news

Blogs on Astrocytoma medical therapy

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

The optimal therapy for astrocytoma depends on the stage at diagnosis. Chemotherapy is recommended for children. Radiation and chemotherapy with stem cell transplant is recommended for adults with high grade astrocytoma.

Medical Therapy

Treatment Options for Childhood Astrocytomas

Newly Diagnosed Childhood Low-Grade Astrocytomas

Recurrent Childhood Low-Grade Astrocytomas

Newly Diagnosed Childhood High-Grade Astrocytomas

Recurrent Childhood High-Grade Astrocytomas

Chemotherapy

High-dose Chemotherapy with Stem Cell Transplant

  • Rapamycin showed efficacy in five cases of SEGA in TSC patients, shrinking their tumor volumes by an average of 65%. However, after the drug was stopped, the tumors regrew.
  • Everolimus which has a similar structure as rapamycin, but with slightly increased bioavailability and shorter half-life, was studied in 28 patients with SEGA. There was a significant reduction in SEGA size in 75% of the patients, and a mild improvement in their seizures. Everolimus was approved for the treatment of SEGA by the US Food and Drug Administration (FDA) in October, 2010.
  • Medicines used to treat primary brain tumors in children include:
  • Comfort measures, safety measures, physical therapy, occupational therapy, and other such steps may be required to improve quality of life.
  • Despite decades of therapeutic research, curative intervention is still nonexistent for high grade astrocytomas; patient care ultimately focuses on palliative management.

Radiation Therapy

References

  1. "National Caner Institute Astrocytoma".

Template:WH Template:WS